Usability Study of "ArmAssist 2.0." Robot: Homecare Arm Rehabilitation in Stroke Patients
PUAA
1 other identifier
interventional
9
1 country
1
Brief Summary
The purpose of this study is to validate the usability of ArmAssist medical device, a robotic system for the rehabilitation of upper limbs in stroke patients (based on serious games). This study evaluate the usability of the system in a home environment, taking into account the ease-to-use, consistency and others; and will pretend demonstrate the feasibility of including or no, robotic therapy in home like complement of daily rehabilitation program. Finally this study investigate the acceptance from patients and therapists.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable stroke
Started Oct 2019
Shorter than P25 for not_applicable stroke
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 28, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2019
CompletedFirst Submitted
Initial submission to the registry
May 19, 2020
CompletedFirst Posted
Study publicly available on registry
May 28, 2020
CompletedJune 4, 2020
June 1, 2020
2 months
May 19, 2020
June 1, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Quebec User Evaluation of Satisfaction with assistive Technology: QUEST scale
The purpose of this scale is to evaluate how satisfied the patient are with the assistive device and the related services they experienced. It consists of twelve questions, eight related to the device and four related to services of 12 satisfaction items with answers from 1 'Not satisfied at all' to 5 'Very satisfied'
Through study completion, an average of 3 weeks
System Usability Scale: SUS
This scale provides a quick, reliable tool for measuring the usability. It consists of 10 item questionnaire and answers from 1 'strongly agree' to 5 'strongly disagree'. Scores are ranging to 0-100 %, where a high score means better usability with a higher score meaning better usability
Through study completion, an average of 3 weeks
Intrinsic Motivation Inventory: IMI
This scale is a multidimensional scale intended to assess participants subjective experience with the device (interest/enjoyment, perceived competence, effort, value/usefulness, felt pressure and tension, and perceived choice while performing a given activity). Consist of 20 item questionnaire with answers from 1 'strongly agree' to 7 'strongly disagree'.
Through study completion, an average of 3 weeks
Usability questionnaire specifically designed for the use of ArmAssist 2.0
It consists of a 19 item questionnaire with seven response options (Likert sacle) for respondents; from Strongly agree to Strongly disagree. To evaluate the satisfaction of patients and therapist with the system and the therapy.
Through study completion, an average of 3 weeks
Structured interviews: Willingness-to-pay questionnaire
This interview consists in two short questions to ask to participants about the willingness-to-pay for ArmAssist 2.0. system as therapy.
Through study completion, an average of 3 weeks
Secondary Outcomes (2)
Fugl-Meyer Assessment (FMA) scale
Baseline, 3 weeks
Modified Asworth Scale (MAS)
Baseline, 3 weeks
Study Arms (1)
ArmAssist group
EXPERIMENTALThe post-stroke patients who participate in the study, are classified in differents stages (3 patients in each stage). Group 1: subacute, between 2 - 6 months Group 2: chronic of short evolution, between 6 - 12 months Group 3: long-term chronic, more than 12 months. The system is tested in a clinical (training) and patients' home setting. The ArmAssist system includes the ArmAsist 2.0 device (without motors), the tele rehabilitation platform based on serious games and Antari's HomeCare tele-care platform for the clinicians.
Interventions
The usability study protocol include 3 ArmAssist systems (2 designed for the left hand and one for the right hand) that could not be used in parallel because the aim of the study was to bring the systems to the home environment during part of the evaluation. The usability study is carried out in two phases: 1. First phase: 5 weeks. 2. Second phase: 3 weeks. Each phase included a week of training at the Hospital or IMIBIC facilities with a physiotherapist, and then 2 weeks at the patient's home, being the first one with the physiotherapist supervision and the second one by their own with the possibility of physiotherapist remote support.
Eligibility Criteria
You may qualify if:
- Subjects over 18,
- Upper limb hemiparesis after stroke,
- Unilateral paresis and cognitive ability to understand,
- Accept and actively participate in the usability study.
You may not qualify if:
- Bilateral motor deficit,
- Severe spasticity,
- Psychiatric illness,
- and/or cognitive impairment.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Maimónides Biomedical Research Institute of Córdobalead
- TECNALIA Research & Innovationcollaborator
- GMV Innovating Solutionscollaborator
Study Sites (1)
Hospital Universitario Reina Sofía de Córdoba
Córdoba, 14004, Spain
Related Publications (1)
Guillen-Climent S, Garzo A, Munoz-Alcaraz MN, Casado-Adam P, Arcas-Ruiz-Ruano J, Mejias-Ruiz M, Mayordomo-Riera FJ. A usability study in patients with stroke using MERLIN, a robotic system based on serious games for upper limb rehabilitation in the home setting. J Neuroeng Rehabil. 2021 Feb 23;18(1):41. doi: 10.1186/s12984-021-00837-z.
PMID: 33622344DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Fernando Jesus Mayordomo Riera, MD
Hospital Universitario Reina Sofia de Córdoba
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 19, 2020
First Posted
May 28, 2020
Study Start
October 28, 2019
Primary Completion
December 30, 2019
Study Completion
December 30, 2019
Last Updated
June 4, 2020
Record last verified: 2020-06
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF, CSR
- Time Frame
- Up to 12 months after trials publication.
- Access Criteria
- Request by e-mail to uicec@imibic.org
All the collected information will be available for other researchers upon request.